Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
17,382
Total Claims
$934K
Drug Cost
522
Beneficiaries
$1,788
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-25%
Opioid rate vs peers
1.9% vs 2.5% avg
+59%
Cost per patient vs peers
$1,788 vs $1,128 avg
+75%
Brand preference vs peers
14.7% vs 8.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.9%
Opioid Rate
322
Opioid Claims
$4,065
Opioid Cost
3.4%
Long-Acting Rate
Brand vs Generic
Brand: 2,531 claims · $731K
Generic: 14,644 claims · $199K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Insulin Glargine,hum.Rec.Anlog | 129 | $63K |
| Dapagliflozin Propanediol | 92 | $57K |
| Sitagliptin Phosphate | 73 | $56K |
| Sitagliptin Phos/Metformin Hcl | 83 | $52K |
| Rivaroxaban | 49 | $42K |
| Levothyroxine Sodium | 696 | $39K |
| Budesonide/Formoterol Fumarate | 74 | $29K |
| Sitagliptin Phos/Metformin Hcl | 39 | $27K |
| Apixaban | 41 | $23K |
| Fluticasone/Vilanterol | 52 | $21K |
| Empagliflozin | 32 | $20K |
| Dulaglutide | 20 | $19K |
| Insulin Nph Hum/Reg Insulin Hm | 47 | $15K |
| Carbidopa/Levodopa | 18 | $13K |
| Saxagliptin Hcl/Metformin Hcl | 18 | $12K |
Prescribing Profile
Patient Profile
71
Avg Age
58%
Female
1.77
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About